<?xml version='1.0' encoding='utf-8'?>
<document id="26200709"><sentence text="Hepatitis C Virus Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic Impairment." /><sentence text="Direct-acting antiviral (DAA) drugs exhibit considerable variability in mechanisms of metabolism and the extent to which they are substrates, inhibitors, or inducers of cytochrome P450 enzymes or P-glycoprotein and other drug transporters" /><sentence text=" Thus, potential drug-drug interactions with other commonly used therapies also vary, as do the effects of renal and hepatic impairment on DAA drug exposure" /><sentence text=" Drug-drug interaction profiles and use in cases of renal or hepatic impairment are reviewed for the DAAs simeprevir; sofosbuvir; ledipasvir; the fixed-dose combination regimen of paritaprevir, ritonavir, and ombitasvir plus dasabuvir; and the investigational drugs daclatasvir and asunaprevir"><entity charOffset="106-116" id="DDI-PubMed.26200709.s4.e0" text="simeprevir" /><entity charOffset="118-128" id="DDI-PubMed.26200709.s4.e1" text="sofosbuvir" /><entity charOffset="130-140" id="DDI-PubMed.26200709.s4.e2" text="ledipasvir" /><entity charOffset="180-192" id="DDI-PubMed.26200709.s4.e3" text="paritaprevir" /><entity charOffset="194-203" id="DDI-PubMed.26200709.s4.e4" text="ritonavir" /><entity charOffset="209-219" id="DDI-PubMed.26200709.s4.e5" text="ombitasvir" /><entity charOffset="225-234" id="DDI-PubMed.26200709.s4.e6" text="dasabuvir" /><entity charOffset="266-277" id="DDI-PubMed.26200709.s4.e7" text="daclatasvir" /><entity charOffset="282-293" id="DDI-PubMed.26200709.s4.e8" text="asunaprevir" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e0" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e1" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e2" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e3" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e4" e2="DDI-PubMed.26200709.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e4" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e4" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e4" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e4" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e5" e2="DDI-PubMed.26200709.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e5" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e5" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e5" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e6" e2="DDI-PubMed.26200709.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e6" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e6" e2="DDI-PubMed.26200709.s4.e8" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e7" e2="DDI-PubMed.26200709.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26200709.s4.e7" e2="DDI-PubMed.26200709.s4.e8" /></sentence><sentence text=" This article summarizes a presentation by Lucas Hill, PharmD, at the IAS-USA continuing education program held in Chicago, Illinois, in October 2014" /><sentence text=" " /></document>